State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Esophagus (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 3.0 to 3.1 and 13,020 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Maine²

• Rate : The incidence rate is 5.3 with a 95% confidence interval from 4.9 to 5.8 and 114 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 2)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 4.5 with a 95% confidence interval from 4.1 to 4.9 and 119 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 8)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 4.2 with a 95% confidence interval from 3.7 to 4.8 and 48 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 20)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.9 to 4.4 and 175 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (2, 12)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.9 to 4.3 and 351 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (2, 10)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.9 to 4.1 and 631 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (3, 11)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.6 to 4.4 and 84 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (2, 20)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.8 to 4.2 and 316 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (3, 14)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.7 to 4.0 and 703 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (5, 15)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.5 to 4.0 and 220 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (4, 20)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.3 to 4.2 and 57 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (2, 32)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.5 to 3.9 and 299 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (6, 21)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.5 to 3.8 and 340 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (8, 21)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.4 to 3.8 and 259 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (8, 24)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.4 to 3.7 and 490 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (10, 22)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.1 to 4.0 and 53 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (3, 36)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 2.9 to 4.2 and 29 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (2, 42)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.0 to 4.1 and 33 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (3, 41)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.4 to 3.6 and 566 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (12, 24)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 2.9 to 4.0 and 34 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (3, 42)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.5 and 161 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (13, 34)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.5 and 187 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (14, 34)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.5 and 164 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (14, 35)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 186 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (16, 36)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.9 to 3.5 and 116 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (14, 39)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 303 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (17, 35)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.9 to 3.5 and 77 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (12, 41)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.9 to 3.4 and 120 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (15, 39)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.4 and 124 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (16, 41)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.8 to 3.4 and 71 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (13, 42)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 416 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (21, 37)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 275 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (20, 38)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.8 to 3.2 and 214 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (21, 40)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.6 to 3.4 and 43 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (14, 47)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.4 to 3.6 and 22 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (9, 51)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.0 and 311 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (28, 42)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.0 and 361 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (29, 42)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.8 to 3.0 and 755 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (31, 41)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.7 to 2.9 and 336 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (32, 43)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.7 to 2.9 and 898 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (34, 43)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 2.9 and 182 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (33, 47)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 2.8 and 211 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (34, 46)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.4 to 2.6 and 780 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (41, 48)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.2 to 2.8 and 50 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (34, 51)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.3 to 2.6 and 162 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (40, 51)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.3 to 2.6 and 232 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (41, 51)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.2 to 2.6 and 93 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (39, 51)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 2.3 with a 95% confidence interval from 2.3 to 2.4 and 1,093 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (44, 51)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 2.3 with a 95% confidence interval from 2.0 to 2.6 and 66 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (41, 51)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 2.3 with a 95% confidence interval from 2.0 to 2.5 and 70 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (41, 51)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 2.1 with a 95% confidence interval from 1.7 to 2.7 and 15 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (34, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 1.2 with a 95% confidence interval from 1.0 to 1.3 and 59 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/24/2026 1:42 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.